[go: up one dir, main page]

WO2003002125A3 - Combination of aminosugars and cysteine or cysteine derivatives - Google Patents

Combination of aminosugars and cysteine or cysteine derivatives Download PDF

Info

Publication number
WO2003002125A3
WO2003002125A3 PCT/DK2002/000446 DK0200446W WO03002125A3 WO 2003002125 A3 WO2003002125 A3 WO 2003002125A3 DK 0200446 W DK0200446 W DK 0200446W WO 03002125 A3 WO03002125 A3 WO 03002125A3
Authority
WO
WIPO (PCT)
Prior art keywords
cysteine
complexes
derivatives
aminosugars
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DK2002/000446
Other languages
French (fr)
Other versions
WO2003002125A2 (en
WO2003002125B1 (en
Inventor
Morten Sloth Weidner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ASTION AS
Original Assignee
ASTION AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ASTION AS filed Critical ASTION AS
Publication of WO2003002125A2 publication Critical patent/WO2003002125A2/en
Publication of WO2003002125A3 publication Critical patent/WO2003002125A3/en
Anticipated expiration legal-status Critical
Publication of WO2003002125B1 publication Critical patent/WO2003002125B1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to chemical complexes consisting of cysteine or derivatives of cysteine and an aminosugar as well as pharmaceutical compositions and dietary supplements comprising such complexes. The invention further relates to the use of such compositions or complexes for the preparation of a medicament or a dietary supplement in the suppresion of hypersensitivity and inflammatory reactions such as rheumatic or dermatological disorders or to a method of treating such diseases by administering such compositions and complexes.
PCT/DK2002/000446 2001-06-29 2002-06-28 Combination of aminosugars and cysteine or cysteine derivatives Ceased WO2003002125A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200101038 2001-06-29
DKPA200101038 2001-06-29
DKPA200101056 2001-07-04
DKPA200101056 2001-07-04

Publications (3)

Publication Number Publication Date
WO2003002125A2 WO2003002125A2 (en) 2003-01-09
WO2003002125A3 true WO2003002125A3 (en) 2003-11-06
WO2003002125B1 WO2003002125B1 (en) 2004-05-21

Family

ID=26069044

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2002/000446 Ceased WO2003002125A2 (en) 2001-06-29 2002-06-28 Combination of aminosugars and cysteine or cysteine derivatives

Country Status (1)

Country Link
WO (1) WO2003002125A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8338387B2 (en) 2004-05-26 2012-12-25 California Institute Of Technology Small molecule stimulators of neuronal growth
US8912149B1 (en) 2007-11-28 2014-12-16 California Institute Of Technology Glycosaminoglycan mimetics
US9770461B2 (en) 2013-08-02 2017-09-26 California Institute Of Technology Tailored glycopolymers as anticoagulant heparin mimetics
US10227370B2 (en) 2013-08-02 2019-03-12 California Institute Of Technology Heparan sulfate/heparin mimetics with anti-chemokine and anti-inflammatory activity

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1232256C (en) * 2003-03-27 2005-12-21 中国人民解放军第三军医大学 Application of N-acetylglucosamine in The preparation of medicine for treating local injure or whole body syndrome due to self immune reaction
US20040247686A1 (en) * 2003-04-04 2004-12-09 Boehringer Ingelheim International Gmbh Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
DE10337638A1 (en) * 2003-08-16 2005-03-24 Kirschfeld, Kuno, Prof. Dr. Method of treating prostatitis
AU2007325972A1 (en) * 2006-10-03 2008-06-05 Galleon Pharmaceuticals, Inc. S-nitrosothiol compounds and related derivatives
ES2325392B1 (en) * 2007-12-28 2010-06-24 Bioiberica, S.A. COMPOSITION FOR THE TREATMENT OF ARTROSIS.
ITRM20080636A1 (en) 2008-11-28 2010-05-29 Univ Palermo PROCEDURE FOR THE PRODUCTION OF FUNCTIONAL DERIVATIVES OF HYALURONIC ACID AND RELATIVE HYDROGELS.
CN102850412B (en) * 2012-10-12 2015-07-22 江苏澳新生物工程有限公司 Preparation method of D-glucosamine sulfate sodium chloride salt

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1283892A (en) * 1970-06-08 1972-08-02 Irwin Irville Lubowe Improvements in and relating to medicinal compositions for application to the skin and/or hair
EP0652012A1 (en) * 1989-03-27 1995-05-10 Albert Naito Combination of sugars with animo acids and other drugs
WO1998033494A1 (en) * 1997-02-04 1998-08-06 Kosbab John V Compositions and methods for prevention and treatment of vascular degenerative diseases
US5895652A (en) * 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
WO1999055326A1 (en) * 1998-04-30 1999-11-04 Vit-Immune, L.C. Method of treatment of glutathione deficient mammals
WO2000007607A1 (en) * 1998-08-04 2000-02-17 Kosbab, John, V. Nutrient and therapeutic compositions for the treatment of cancer
WO2001013865A1 (en) * 1999-08-20 2001-03-01 Howard Murad Pharmaceutical compositions and methods for reducing the appearance of cellulite
US6231889B1 (en) * 1998-09-21 2001-05-15 Chronorx, Llc Unit dosage forms for the treatment of herpes simplex
WO2002004003A2 (en) * 2000-07-10 2002-01-17 N.V. Nutricia Composition for the treatment of osteoarthritis

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1283892A (en) * 1970-06-08 1972-08-02 Irwin Irville Lubowe Improvements in and relating to medicinal compositions for application to the skin and/or hair
EP0652012A1 (en) * 1989-03-27 1995-05-10 Albert Naito Combination of sugars with animo acids and other drugs
US5895652A (en) * 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
WO1998033494A1 (en) * 1997-02-04 1998-08-06 Kosbab John V Compositions and methods for prevention and treatment of vascular degenerative diseases
WO1999055326A1 (en) * 1998-04-30 1999-11-04 Vit-Immune, L.C. Method of treatment of glutathione deficient mammals
WO2000007607A1 (en) * 1998-08-04 2000-02-17 Kosbab, John, V. Nutrient and therapeutic compositions for the treatment of cancer
US6231889B1 (en) * 1998-09-21 2001-05-15 Chronorx, Llc Unit dosage forms for the treatment of herpes simplex
WO2001013865A1 (en) * 1999-08-20 2001-03-01 Howard Murad Pharmaceutical compositions and methods for reducing the appearance of cellulite
WO2002004003A2 (en) * 2000-07-10 2002-01-17 N.V. Nutricia Composition for the treatment of osteoarthritis

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8338387B2 (en) 2004-05-26 2012-12-25 California Institute Of Technology Small molecule stimulators of neuronal growth
US8912149B1 (en) 2007-11-28 2014-12-16 California Institute Of Technology Glycosaminoglycan mimetics
US9770461B2 (en) 2013-08-02 2017-09-26 California Institute Of Technology Tailored glycopolymers as anticoagulant heparin mimetics
US10227370B2 (en) 2013-08-02 2019-03-12 California Institute Of Technology Heparan sulfate/heparin mimetics with anti-chemokine and anti-inflammatory activity

Also Published As

Publication number Publication date
WO2003002125A2 (en) 2003-01-09
WO2003002125B1 (en) 2004-05-21

Similar Documents

Publication Publication Date Title
AU2903300A (en) Novel pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing medicament or a dietary supplement for thetreatment or prevention of inflammation, hypersensitivity reactions or pain
WO2001090091A8 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2006014673A3 (en) Insulin-oligomer conjugates, formulations and uses thereof
GEP20022788B (en) Pharmaceutical Compositions Having Appetite Suppressant Activity
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
MX9605940A (en) Bio-aromatic compounds carrying an adamantyl group in ortho, pharmaceutical and cosmetic compositions containing them and utilization.
WO2003022210A3 (en) Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith
WO2008058547A3 (en) Alpha-lactalbumin composition
AU2002351583A1 (en) Chitosan oligosaccharides and uses thereof
WO2003002125A3 (en) Combination of aminosugars and cysteine or cysteine derivatives
IL122196A0 (en) Bicyclic-aromatic compounds
PT1200106E (en) COMPOSITION CONTAINING BUTYROSPERMUM PARKII EXTRACTS AND USES AS A MEDICATION OR DIETETIC SUPPLEMENT
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
HUP0304077A2 (en) Pharmaceutical and cosmetic compositions against skin aging
WO2007056264A3 (en) Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
WO2003050067A3 (en) Vitamin d analogues
PL367812A1 (en) Alpha-ketoglutarates of active ingredients and compositions containing same
WO2003018535A3 (en) Novel aminobenzoephenones
WO2003002117A3 (en) Niaciamide and derivatives in combination with aminosugar
WO2004033484A3 (en) Use of stable glutamine derivatives to improve drug absorption
WO2003043632A3 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
JP4584453B2 (en) Composition comprising a mixture of bioflavonol
WO2004030684A3 (en) Kavalactone product
Ali Use of acacia gum in the treatment of skin lesions of two children with Kwashiorkor
CA2620313A1 (en) Nutritional method for elderly people

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

B Later publication of amended claims

Effective date: 20021213

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP